Chinese Stocks To Watch Today – November 17th

Diageo, UP Fintech, RBB Bancorp, Regencell Bioscience, and China SXT Pharmaceuticals are the five Chinese stocks to watch today, according to MarketBeat’s stock screener tool. “Chinese stocks” are shares of companies based in China or primarily tied to the Chinese economy. They may trade on mainland exchanges or abroad, including as Hong Kong-listed shares or U.S.-listed depositary receipts, and can be subject to different market rules and investor-access restrictions. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Shares of DEO stock traded down $0.79 during mid-day trading on Tuesday, reaching $101.37. The company’s stock had a trading volume of 449,951 shares, compared to its average volume of 1,427,893. The company’s 50 day simple moving average is $91.22 and its 200-day simple moving average is $86.42. Diageo has a 12-month low of $72.45 and a 12-month high of $102.74. The company has a debt-to-equity ratio of 1.53, a quick ratio of 0.62 and a current ratio of 1.60.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

TIGR stock traded down $0.34 during midday trading on Tuesday, hitting $3.69. 1,355,180 shares of the company’s stock were exchanged, compared to its average volume of 3,060,099. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06. UP Fintech has a 12-month low of $3.61 and a 12-month high of $11.35. The firm has a 50 day moving average price of $4.34 and a 200-day moving average price of $5.59. The stock has a market capitalization of $700.94 million, a price-to-earnings ratio of 6.23 and a beta of 0.65.

Read Our Latest Research Report on TIGR

RBB Bancorp (RBB)

RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.

Shares of RBB traded down $0.38 during midday trading on Tuesday, hitting $25.45. The company had a trading volume of 11,219 shares, compared to its average volume of 111,989. The stock has a market cap of $425.20 million, a price-to-earnings ratio of 9.86 and a beta of 1.06. The company’s 50 day moving average price is $26.16 and its 200 day moving average price is $24.64. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.52. RBB Bancorp has a 52 week low of $18.45 and a 52 week high of $28.24.

Read Our Latest Research Report on RBB

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Shares of NASDAQ RGC traded down $0.24 during trading on Tuesday, reaching $4.48. The stock had a trading volume of 32,983 shares, compared to its average volume of 289,220. Regencell Bioscience has a one year low of $4.41 and a one year high of $69.00. The firm’s 50 day moving average price is $6.75 and its two-hundred day moving average price is $15.86.

Read Our Latest Research Report on RGC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

SXTC traded down $0.16 on Tuesday, hitting $2.83. 27,397 shares of the company’s stock were exchanged, compared to its average volume of 70,330. The company has a debt-to-equity ratio of 0.02, a current ratio of 7.94 and a quick ratio of 7.76. The stock has a fifty day moving average of $109.93 and a two-hundred day moving average of $10,458.09. China SXT Pharmaceuticals has a twelve month low of $2.71 and a twelve month high of $8,375,880.00.

Read Our Latest Research Report on SXTC

Read More